Anastrozole

Description

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women.

Medicine classification

ATC Code
Title
Class
L02BG03
Anastrozole
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors

Medicines

Drug
Countries
AMENUR

Spain

ANASTROL

Australia

ANASTROLAN

Austria

ANESTRA

Singapore

ANEXTROZOLE

Singapore

ANOTROLE

Hong Kong

ANZONAT

Hong Kong Singapore

AREMED

Cyprus Hong Kong Singapore

ARIANNA 1

Australia

ARIMIDEX

Australia Austria Canada Cyprus France

AROMATT

Singapore

AXASTROL

Lithuania

FEMIZET

Hong Kong Singapore

STRAZOLAN

Cyprus

VALEX

Cyprus

Product monographs

Monograph
Type
Country
ARIMIDEX Film-coated tablets
MPI, EU: SmPC
UK

2D Molecule Structure

2D representation of molecule

3D Molecule Structure

3D representation of molecule

Unique Ingredient Identifier (UNII)

2Z07MYW1AZ - ANASTROZOLE

CAS Registry Number

120511-73-1 - anastrozole

SNOMED-CT

386910003 - Anastrozole (substance)

Usage: Next >